Dexmedetomidine 200 mcg/2 ml belongs to the generic category of Dexmedetomidine. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Dexmedetomidine 200 mcg/2 ml. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Dexmedetomidine and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

*Up to 10% Discount
(Depends on pharmacy)
/ 2 ml ampoule
Dexmedetomidine 200 mcg/2 ml may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Dexmedetomidine 200 mcg/2 ml is provided below to help users gain a clear understanding of this medicine.
Dexmedetomidine is a relatively selective alpha2-adrenergic agonist indicated for:
Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Administer Dexmedetomidine by continuous infusion not to exceed 24 hours.
Sedation of non-intubated patients prior to and/or during surgical and other procedures.
Dexmedetomidine is a specific and selective alpha-2 adrenoceptor agonist. By binding to the presynaptic alpha-2 adrenoceptors, it inhibits the release if norepinephrine, therefore, terminate the propagation of pain signals. Activation of the postsynaptic alpha-2 adrenoceptors inhibits the sympathetic activity decreases blood pressure and heart rate.
Individualize and titrate Dexmeditomidine dosing to desired clinical effect.Administer Dexmeditomidine using a controlled infusion device.Dilute the 200 mcg/2 mL (100 mcg/mL) vial contents in 0.9% sodium chloride solution to achieve required concentration (4 mcg/mL) prior to administration.The 200 mcg/50 mL single-use bottles do not require further dilution prior to administration.For Adult Intensive Care Unit Sedation: Generally initiate at one mcg/kg over 10 minutes, followed by a maintenance infusion of 0.2 to 0.7 mcg/kg/hour.For Adult Procedural Sedation: Generally initiate at one mcg/kg over 10 minutes, followed by a maintenance infusion initiated at 0.6 mcg/kg/hour and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/hour. Alternative Doses: Recommended for patients over 65 years of age and awake fiberopticintubation patients.
Co-administration of Dexmedetomidine with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.
Body as a Whole: Fever, hyperpyrexia, hypovolemia, light anesthesia, pain, rigorsCardiovascular Disorders, General: Blood pressure fluctuation, heart disorder, hypertension, hypotension, myocardial infarctionCentral and Peripheral Nervous System Disorders: Dizziness, headache, neuralgia, neuritis, speech disorder, convulsionGastrointestinal System Disorders: Abdominal pain, diarrhea, vomiting, nauseaLiver and Biliary System Disorders: Increased gamma-glutamyl transpeptidase, hepatic function abnormal, hyperbilirubinemiaMetabolic and Nutritional Disorders: Acidosis, respiratory acidosis, hyperkalemia, thirst, hypoglycemia Psychiatric Disorders: Agitation, confusion, delirium, hallucination, illusionRed Blood Cell Disorders: AnemiaRenal Disorders: Blood urea nitrogen increased, oliguriaRespiratory System Disorders: Hypoventilation, hypoxia, pulmonary congestionSkin Disorders: Increased sweatingVascular Disorders: HemorrhageVision Disorders: Photopsia, abnormal vision.
Pregnancy Category C.
Continuous monitoring is needed while patient receiving Dexmedetomidine.
Miscellaneous sedatives & hypnotics
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023